PETALING JAYA: The Covid-19 vaccine produced by Pfizer-BioNTech has obtained the approval of the National Pharmaceutical Regulatory Agency which means it can now be administered in Malaysia.
Science, Technology, and Innovation Minister Khairy Jamaluddin said he had been informed by health director-general Dr Noor Hisham Abdullah that the NPRA had given conditional registration for the vaccine.
“We are still waiting for a few additional information from Pfizer but this means it can be used in Malaysia. Congratulations NPRA on the quick registration,” he said in a Twitter post.
The vaccine was co-developed by US-based Pfizer Inc and the German biotechnology firm BioNTech. Two doses per person are required for vaccination. The companies say the vaccine is more than 90% effective.
Malaysian authorities signed an agreement with Pfizer in November last year to obtain its Covid-19 vaccine to innoculate 20% of the population, about 6.4 million people.
Khairy previously announced that the Pfizer vaccine, which must be kept in ultra-low temperatures, will be placed across 55 urban areas, and vaccines that can be stored under normal refrigerator temperatures will be deployed in more rural areas.
CLICK HERE FOR THE LATEST DATA ON THE COVID-19 SITUATION IN MALAYSIA